Keryx Biopharmaceuticals (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to market for people with renal disease, today announced its financial results for …
Healthcare analysts weighed in today with positive reports on biopharmaceutical companies Relypsa Inc (NASDAQ:RLYP) and Keryx Biopharmaceuticals (NASDAQ:KERX). The analysts reflect on Relypsa’s positive results from Veltassa’s …
Many call Seth Klarman a modern day investing legend due to his expertise in value investing. However in the third quarter, Klarman’s hedge …
Keryx Biopharmaceuticals (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for people with renal disease, today announced that John P. Butler …
Keryx Biopharmaceuticals (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for people with renal disease, today announced its financial results for …
Maxim’s healthcare analysts are weighing in on the Boston drug company Keryx Biopharmaceuticals (NASDAQ:KERX) and cancer drug discovery company Kite Pharma Inc (NASDAQ:KITE), following recent announcements. Keryx Biopharmaceuticals In a …
J.P.
Facebook Inc (NASDAQ:FB) spiked 1.03% in pre-market trading up to $95.
Keryx Biopharmaceuticals (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for people with renal disease, today announced that it has entered …
American billionaire Seth Klarman is the founder of the Baupost Group, the world’s 11th largest hedge fund. Klarman’s portfolio is valued at $6 …
